Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter H Moos

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Biochemical Pharmacology|May 2, 2015
A tribute to David TriggleWalter H Moos
Drug Development Research|April 3, 2015
Mitochondrial drugs come of ageWalter H Moos, James A Dykens
Protein and Peptide Letters|February 2, 2019
Peptides 2020: A Clear Therapeutic VisionYvonne Angell, Mandë Holford, Walter H Moos
Protein and Peptide Letters|November 16, 2018
Building on Success: A Bright Future for Peptide TherapeuticsYvonne Angell, Mandë Holford, Walter H Moos
Annals of the New York Academy of Sciences|July 19, 2005
Development of 17alpha-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical studyJames A Dykens, Walter H Moos, Neil Howell
Molecular Diversity|March 4, 2009
Combinatorial chemistry: oh what a decade or two can doWalter H Moos, Clarence R Hurt, Guillermo A Morales
FASEB Bioadvances|June 14, 2021
Are in-person scientific conferences dead or alive?Nick Dua, Mattias Fyrenius, Deborah L Johnson, et al.
Drug Development Research|June 26, 2015
Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: mitochondrial drugs come of ageKosta Steliou, Douglas V Faller, Carl A Pinkert, et al.
Drug Development Research|February 23, 2016
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson DiseasesMichael H Irwin, Walter H Moos, Douglas V Faller, et al.
Bioresearch Open Access|June 9, 2016
Microbiota and Neurological Disorders: A Gut FeelingWalter H Moos, Douglas V Faller, David N Harpp, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Biochemical Pharmacology|May 2, 2015
A tribute to David TriggleWalter H Moos
Drug Development Research|April 3, 2015
Mitochondrial drugs come of ageWalter H Moos, James A Dykens
Protein and Peptide Letters|February 2, 2019
Peptides 2020: A Clear Therapeutic VisionYvonne Angell, Mandë Holford, Walter H Moos
Protein and Peptide Letters|November 16, 2018
Building on Success: A Bright Future for Peptide TherapeuticsYvonne Angell, Mandë Holford, Walter H Moos
Annals of the New York Academy of Sciences|July 19, 2005
Development of 17alpha-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical studyJames A Dykens, Walter H Moos, Neil Howell
Molecular Diversity|March 4, 2009
Combinatorial chemistry: oh what a decade or two can doWalter H Moos, Clarence R Hurt, Guillermo A Morales
FASEB Bioadvances|June 14, 2021
Are in-person scientific conferences dead or alive?Nick Dua, Mattias Fyrenius, Deborah L Johnson, et al.
Drug Development Research|June 26, 2015
Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: mitochondrial drugs come of ageKosta Steliou, Douglas V Faller, Carl A Pinkert, et al.
Drug Development Research|February 23, 2016
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson DiseasesMichael H Irwin, Walter H Moos, Douglas V Faller, et al.
Bioresearch Open Access|June 9, 2016
Microbiota and Neurological Disorders: A Gut FeelingWalter H Moos, Douglas V Faller, David N Harpp, et al.
Pageof 3